GSK_ Annual_Report_2021-22

73 Annexure ‘E’ to Director’s Report Disclosure pursuant to Section 134(3)(M) of the Companies Act, 2013, read with Rule 8 of the Companies (Accounts) Rules, 2014 a) Conservation of Energy During the year, Nashik site has undertaken various initiatives for energy and water conservation to reduce energy consumption at the site, such as installation of 100KWp Solar PV for electricity generation, adoption of LED lighting, installation of EC drive for AHUs etc. Due to these efforts, despite higher production volumes as compared to last year, the CO 2 consumption has marginally increased by 0.7%. The site has reduced its water consumption by 6204kl during the year, through water saving projects including enhanced usage of rainwater in boiler, recycled ETP treated water for cooling towers, resulting in reduction of 6.6% as compared to last year. b) Technology absorption: • Implementation of CRSF caps for the bottles of all SKUs of Eltroxin. • Removal of high noise DG set, ensuring generator area is free from mandated hearing protection, replacing it with acoustic enclosure Genset. • Installation of site wide Public Address System and upgrading the assembly points for emergency response. • Upgradation of all safety related parts of control systems of identified high risk equipment to the machinery safety standards. • Installation of condition monitoring system on 1600 kVA transformer for online monitoring of parameters. • Completion of upgrades in the facility & effluent stream, achieving compliance to AMR requirements. • Improving the equipment capability & compliance on data integrity by upgrading equipment - Dissolution Media Degasser, Dissolution Tester, Sonicator, Microscope & Tablet Compression machines. • Deployment of platform for e-validation, ensuring electronic generation, execution & approval of validation documents, migrating to a paperless process. • Deployment of geo segmentation, anetwork fire wall protection project to ensure cyber security controls are in place. • Installation of dehumidifier system for tablet testing in the QC Lab to meet controlled condition testing requirements. • Installation of new dust collection units in the Ointment & Tablet facility, to improve controls on chemical exposure and mitigating risks. c) Foreign exchange earnings and Outgo: The foreign exchange earnings for the year ended 31 March 2022 was ` 5277.79 lakhs and foreign exchange outgo for the year ended 31 March 2022 was ` 88525.82 lakhs. The foreign exchange earnings for the period ended 31 March 2021 was ` 2780.23 lakhs and foreign exchange outgo for the period ended 31 March 2021 was ` 113971.49 lakhs. On behalf of the Board of Directors Ms. R. S. Karnad Mumbai, 16 May 2022 Chairperson